← All trials
NCT00806234
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2009
- Primary completion
- Mar 1, 2014
- Completion date
- Mar 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 127
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Johns Hopkins UniversityLead sponsor
- University of MarylandOverall official - principal investigator
- The Zucker Hillside HospitalOverall official - principal investigator
- Johns Hopkins UniversityOverall official - principal investigator
- University of North Carolina at Chapel HillOverall official - principal investigator
- National Institute of Mental Health (NIMH)Collaborator
- University of MarylandCollaborator
- The Zucker Hillside HospitalCollaborator
- University of North Carolina at Chapel HillCollaborator
- Johns Hopkins UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.